Replies to post #122996 on Biotech Values

[genisi]

current SOC for GT2/GT3 patients is 24 weeks of Peg/Riba.

Do you know what part of the GT2/3 patients population get a shorter 16 weeks course (depending on having low baseline viral load and perhaps RVR)?